The IL-17 Differentiation Pathway and Its Role in Transplant Outcome
Open Access
- 1 January 2012
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 18 (1) , S56-S61
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cellsBone Marrow Transplantation, 2011
- Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow TransplantationClinical Cancer Research, 2011
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantationJournal of Clinical Investigation, 2010
- How are TH2-type immune responses initiated and amplified?Nature Reviews Immunology, 2010
- IL-21 is critical for GVHD in a mouse modelBone Marrow Transplantation, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestationsBlood, 2009
- Structure–function relationships in the IL-17 receptor: Implications for signal transduction and therapyCytokine, 2008
- Th17: the third member of the effector T cell trilogyCurrent Opinion in Immunology, 2007
- IL-25 regulates Th17 function in autoimmune inflammationJournal of Experimental Medicine, 2007